Table 4.
Clinical Outcome Data Presented per Study.
| Author | Clinical outcome measure | Preoperative value | Final follow-up value | Delta | ||
|---|---|---|---|---|---|---|
| Tether (tether only (TO) + tether and crosslink (TC)) | ||||||
| Alluri et al 2020 28 | ODI | PS | 61 | 55* | 6* | |
| TC | 58 | 42* | 16* | |||
| 2 level prophylactic vertebroplasty (2-PVP) | ||||||
| Martin et al 2013 38 | ODI | 82.88 | 25.04‡ | 57.84 | ||
| SF-36 | Physical health | 45.83 | 41.46‡ | 4.37 | ||
| Mental health | 70.2 | 51.21‡ | 18.99 | |||
| SRS-24 | Function/activity | 54.22 | 64.74‡ | 10.52 | ||
| Pain | 44.31 | 70.61‡ | 26.3 | |||
| Mental health | 54.90 | 58.71‡ | 3.81 | |||
| Satisfaction | 53.05 | 74.75‡ | 21.70 | |||
| Theologis and Burch 2015 40 | EQ | VAS | PS | 71 ± 19 (n = 18) | 61 ± 22 (n = 22) | 10 |
| 2-PVP | 63 ± 25 (n = 19) | 74 ± 23 (n = 18) | 11* | |||
| 5-D Utility | PS | 0.44 ± 0.21 (n = 18) | 0.50 ± 0.22 (n = 22) | 0.06 | ||
| 2-PVP | 0.51 ± 0.18 (n = 19) | 0.65 ± 0.22 (n = 18) | 0.14* | |||
| ODI | PS | 52 ± 20 (n = 18) | 47 ± 18 (n = 22)‡ | 5 | ||
| 2-level vertebroplasty | 47 ± 14 (n = 13) | 32 ± 17 (n = 17)‡ | 15* | |||
| VAS | Back pain | PS | 5.9 ± 3.0 (n = 14) | 5.2 ± 1.9 (n = 12) | 0.7 | |
| 2-PVP | 6.8 ± 2.6 (n = 5) | 3.4 ± 3.4 (n = 10) | 3.4* | |||
| Leg pain | PS | 6.0 ± 3.4 (n = 14) | 2.4 ± 2.7 (n = 12) | 3.6* | ||
| 2-PVP | 4.0 ± 3.4 (n = 7) | 1.2 ± 2.0 (n = 10) | 2.8* | |||
| Transverse process hooks (TPH) | ||||||
| Hassanzadeh et al 2013 41 | ODI | PS | 72 (48-90) | 32 (0-54‡ | 40 | |
| TPH | 76 (52-90) | 18 (8-38)‡ | 58 | |||
| SRS-22 | Function | PS | 2.4 (1.7-3) | 3.1 (2.5-3.7)‡ | 0.7* | |
| TPH | 2.4 (1-3.3) | 3.6 (3-4.1)‡ | 1.2* | |||
| Pain | PS | 1.7 (0.3-3.1) | 3.2 (2.6-4.3)‡ | 1.5* | ||
| TPH | 1.8 (0.9-2.4) | 4.3 (3.4-4.8)‡ | 2.5* | |||
| Self-image | PS | 2.1 (0.9-3) | 2.4 (1.2-3.6)‡ | 0.3* | ||
| TPH | 1.8 (0.5-3.4) | 4.2 (2.6-5.3)‡ | 2.4* | |||
| Mental Health | PS | 1.8 (1.1-2.5) | 3 (2.3-3.3)‡ | 1.2* | ||
| TPH | 1.7 (1.2-2.6) | 3.8 (3.2-4.1)‡ | 2.1* | |||
| Satisfaction | PS | 1.2 (0.1-4.5) | 3.4 (2.3-4.6)‡ | 2.2* | ||
| TPH | 1.6 (0-4.1) | 4.3 (3.5-5.5)‡ | 3.2* | |||
| Sublaminar tapes (ST) | ||||||
| Viswanathan 2018 45 |
ODI | 56.0 (45.0-64.0) | 46.0 (22.2-54.0) | 10.0* | ||
| VAS | Pain | 12.5 (0.0-22.5) | 45.0 (22.5-67.5) | 32.5* | ||
| Back pain | 8.0 (6.0-10.0) | 2.0 (0.0-6.0) | 6.0* | |||
| Leg pain | 8.0 (6.0-10.0) | 0.5 (0.0-5.0) | 7.5 | |||
| SF-36 | Physical | 20.0 (5.0-30.0) | 32.5 (17.5-53.8) | 12.5* | ||
| Social functioning | 37.5 (12.5-50.0) | 56.3 (37.5-96.9) | 18.8* | |||
Data is presented as “mean value ± Standard Deviation” or “median (range).”
* Indicates that the mentioned study has reported these values as significantly different between groups.
‡Indicates that the mentioned study reported a significant improvement from pre-operative to final follow-up.
2-PVP: 2-level prophylactic vertebroplasty, PS: pedicle screw at the UIV (control group), ST: sublaminar tapes, TPH: transverse process hooks.